§262a. Enhanced control of dangerous biological agents and toxins — Inbound Citations
42 U.S.C. § 262a
Cited by 8 provisions in release 119-102.
Citations to 42 U.S.C. § 262a as a whole
-
(9) collaborating with the Secretary of Health and Human Services and the Attorney General in determining any new biological agents and toxins that shall be listed as “select agents” in Appendix A of part 72 of title 42, Code of Federal Regulations, pursuant to section 262a of title 42;
-
(B) The term “section 351A program” means the program under section 351A of the Public Health Service Act [42 U.S.C. 262a].
-
(A) is listed as a non-overlap or overlap select biological agent or toxin under part 73 of title 42, Code of Federal Regulations, pursuant to section 351A of the Public Health Service Act (42 U.S.C. 262a); and
Citations to §262a(a)(1)
-
(bb) are listed pursuant to section 262a(a)(1) of title 42.3
-
(bb) is listed pursuant to section 262a(a)(1) of title 42.3
-
(i) is listed pursuant to section 315A(a)(1)1 of the Public Health Service Act [42 U.S.C. 262a(a)(1)], as added by section 201 of this Act; and
-
(A) a priority to treat, identify, or prevent infection by a biological agent or toxin listed pursuant to section 262a(a)(1) of this title, or harm from any other agent that may cause a public health emergency; or
-
(1) Beginning not later than 60 days after December 29, 2022, the Secretary of Health and Human Services shall not fund research conducted by a foreign entity at a facility located in a country of concern, in the estimation of the Director of National Intelligence or the head of another relevant Federal department or agency, as appropriate, in consultation with the Secretary of Health and Human Services, involving pathogens of pandemic potential or biological agents or toxins listed pursuant to section 351A(a)(1) of the Public Health Service Act (42 U.S.C. 262a(a)(1)).